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Langerhans Cells in CD44-Deﬁcient Mice Emigrate from the
Epidermis But Fail to Reach the Lymph Nodes After Hapten
Application
To the Editor:
Langerhans cells are members of the dendritic cell (DC)
family that reside in the epithelial tissue, including epider-
mis. Exposure of skin to haptens or pro-inflammatory stimuli
results in Langerhans cell emigration from the epidermis to
the draining lymph node. At the same time, they acquire
features of mature DC, such as elevated surface expression
of major histocompatibility complex II, induced expression
of costimulatory molecules, and production of inflammatory
cytokines and chemokines.
Migration of Langerhans cells from the skin to the lymph
node requires a number of adhesion molecules, including
selected CD44 isoforms (Osada et al, 1995; Weiss et al,
1997). CD44 is an integral membrane protein that binds a
variety of ligands and reportedly plays functional roles in a
number of biologic events. The array of potential CD44
ligands, as well as its varied biologic functions, reflects
expression of numerous CD44 isoforms generated by
extensive alternative splicing and post-translational mod-
ifications (reviewed in Isacke and Yarwood, 2002).
In the original description of CD44–/– mice, it was
reported that these animals exhibited normal contact
hypersensitivity (CHS) responses to dinitrofluorobenzene
(DNFB) compared with CD44þ /– littermates (Schmits et al,
1997). In contrast, CD44 anti-sense transgenic mice (under
control of the keratin 5 promoter, termed K5-CD44 mice)
showed markedly diminished CHS responses to the same
hapten compared with wild-type controls (Kaya et al, 1999).
Most recently, CHS responses to DNFB have been com-
pared between CD44–/– and CD44þ /þ mice (McKallip et al,
2002). Unlike either of the above findings, CD44–/– mice
showed augmented ear swelling responses compared with
CD44þ /þ animals. The apparent discordance in the above
reports has generated confusion as to the potential roles of
CD44 in CHS. Moreover, none of the above studies directly
evaluated the role of CD44 in Langerhans cell homing. In
this study, we sought to determine whether CD44–/– mice
exhibit any abnormality in Langerhans cell emigration from
the epidermis and/or in their subsequent homing to draining
lymph nodes. All animal experiments were approved by the
institutional review board at University of Texas South-
western Medical Center and according to the guidelines
from the National Institutes of Health.
Numbers of Langerhans cells in the epidermis of vehicle-
treated ears were comparable (p40.1) between wild-type
(495  91 per mm2) and CD44–/– mice (459  76 per mm2)
(Fig 1A). Topical application of oxazolone on ear skin re-
sulted in marked reductions in Langerhans cell densities in
both wild-type (30  7%) and CD44–/– animals (39  11%).
The extent of emigration was not significantly different
between wild-type and CD44–/– mice (p40.1). Because
previous studies on CHS responses in CD44–/– and CD44
anti-sense transgenic mice employed DNFB as a hapten,
we next evaluated Langerhans cell migration after topical
application of DNFB on ear skin. Reductions in surface
densities of Langerhans cells were comparable between
wild-type (20%) and CD44–/– mice (16%). To study lymph
node-directed homing of migratory Langerhans cells, we
applied fluorescein-5-isothiocyanate (FITC) and counted
the number of CD11cþ /FITCþ cells in the draining lymph
nodes. Separate experiments confirmed that FITC also
triggered comparable epidermal Langerhans cell emigration
between wild-type and CD44–/– animals (Fig 1B). In wild-
type mice, large numbers of CD11cþ /FITCþ cells were
detected in lymph nodes 24 to 48 h after FITC application
(Fig 2). In contrast, much smaller numbers of CD11cþ /
FITCþ cells were found in lymph nodes of CD44–/– mice at
both 24 h and 48 h (po0.05). Thus, CD44 appears to play
an essential part in Langerhans cells homing to lymph
nodes, but not in their emigration from the epidermis.
Figure1
Hapten-triggered Langerhans cell migration in wild-type and
CD44–/– mice. (A) Oxazolone (open bar) or vehicle alone (closed bar)
was applied to the ears of wild-type or CD44–/– mice. Ear skin samples
were harvested 24 h later and examined for the surface densities of IAþ
epidermal Langerhans cells using FITC-conjugated 2G9 monoclonal
antibody. (B) FITC (open bar) or vehicle alone (closed bar) was applied
to the ears of wild-type or CD44–/– animals. After 24 h, ear skin samples
were harvested and examined for epidermal Langerhans cells densities
using phycoerythrin-conjugated 2G9. Green fluorescence signals were
eliminated using a U-MWIY2 mirror unit (Olympus). Data shown are the
mean  SD (n¼ 3) of Langerhans cell numbers in the epidermis,
representative of two independent experiments with similar results.
Statistically significant differences are indicated with asterisks
(po0.01; Student’s t test).
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Other investigators have reported that splenic and
thymic CD44–/– lymphocytes, when injected intravenously
into CD44þ /þ , CD44þ /–, and CD44–/– recipients, showed
impaired homing to lymph nodes (regardless of the genetic
background of the recipient) within the first 2 h postinjection
period compared with CD44þ /þ lymphocytes (Protin et al,
1999). Interestingly, at 24 h after injection, significantly
greater numbers of CD44–/– lymphocytes migrated to the
lymph nodes (termed ‘‘overcompensation’’) than did
CD44þ /þ lymphocytes. Our findings on CD44–/– Langer-
hans cells appear to duplicate those on CD44–/– lympho-
cytes at the early time point. In contrast, we did not find
overcompensation of Langerhans cells homing to lymph
nodes, perhaps reflecting different mechanisms by which
leukocytes achieve homing to lymph nodes via blood
vessels versus lymphatic vessels.
Based on our findings that Langerhans cell homing to
lymph nodes is impaired in CD44–/– mice, one would predict
that CHS responses should be attenuated in these animals.
In fact, a previous study utilizing transgenic K5-CD44 anti-
sense mice showed significantly reduced ear swelling
responses (Kaya et al, 1999). As K5-CD44 mice have a
metabolic defect characterized by the accumulation of large
amounts of hyaluronan in the dermis, these authors
suggested that Langerhans cells get ‘‘stuck’’ in the dermis
and are unable to migrate to the lymph node and thus
efficiently sensitize the mice (Kaya et al, 1999). These
findings are in sharp contrast to the initial report on CHS
responses in CD44–/– mice showing no significant differ-
ences in ear swelling responses compared with CD44þ /–
littermates (Schmits et al, 1997). As has been pointed out by
others, however, these original observations may be
misleading as CD44þ /– animals were used as controls
(McKallip et al, 2002). Because CD44þ /– mice express
reduced amounts of CD44 on cell surfaces compared with
CD44þ /þ controls (Schmits et al, 1997), it is possible that
CD44þ /– leukocytes are partially or completely defective in
CD44-mediated functions during CHS responses. If so,
differences between CD44þ /– and CD44–/– animals may not
exist or may be too small for detection by the ear swelling
assay. Finally, the most recent report on CHS responses in
CD44–/– mice employed CD44þ /þ animals for comparison
(McKallip et al, 2002). This group found that CD44–/– mice
actually exhibited augmented CHS responses, which may
first appear to contradict our finding of impaired Langer-
hans cells homing to the lymph nodes. These authors,
however, also observed that CD44–/– T cells were resistant
to T cell receptor-mediated apoptosis, whereas signaling
through CD44 in wild-type Tcells led to increased apoptosis
in activated, but not resting, states. Thus, increased CHS
responses observed in CD44–/– mice may be explained by
the failure of CD44–/– T cells to undergo activation-induced
cell death. As shown in Fig 2, although Langerhans cell
homing to the lymph nodes is significantly diminished in
CD44–/– mice, it is not completely abrogated. We propose
that even a relatively small number of Langerhans cells that
have homed to the lymph node may be sufficient to
sensitize CD44–/– mice at least to some extent. If so, the
resistance of activated CD44–/– T cells to undergo apoptotic
death may mask the consequence of impaired homing of
CD44–/– Langerhans cells.
In conclusion, we report that CD44 deficiency does not
impair Langerhans cell emigration from the epidermis, but
significantly impacts their lymph node homing. We believe
that our observations clarify the current conflict with regard
to the physiologic role of CD44 in CHS responses.
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Figure 2
Lymph node-directed homing of Langerhans cells. The fluorescent
hapten FITC was applied to the abdominal skin of wild-type (closed
circles) or CD44–/– (open circles) animals. Mice were euthanized 24 h, 48
h, and 72 h after FITC painting and axillary and inguinal lymph nodes
harvested. Numbers of CD11cþ /FITCþ cells were determined by FACS.
Data shown are the mean  SD (n¼ 3) representative of two indepen-
dent experiments with similar results. Statistically significant differences
are indicated with asterisks (po0.05, po0.01; Student’s t test).
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